Evolution of Biosensors and Current State-of-the-Art Applications in Diabetes Control
Biosensors · 03.01.2026 · 16 (1) · 39
DOI: 10.3390/bios16010039 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors, online erschienen am 03.01.2026. Verfasst von Yahya Waly und 6 weiteren Autor:innen. Beteiligte Einrichtung: Materials for Medicine Research Group, School of Medicine, Royal College of Surgeons in Ireland, Medical University of Bahrain, Busaiteen 228, Bahrai…. Hauptthemen laut MEDLINE: Biosensing Techniques, Diabetes Mellitus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: School of Postgraduate Studies and Research, RCSI-Bahrain.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes is a chronic metabolic disorder that poses a growing global health challenge, currently affecting nearly 500 million people. Over the past four decades, the rising prevalence of diabetes has highlighted the urgent need for innovations in monitoring and management. Traditional enzymatic methods, including those using glucose oxidase, glucose dehydrogenase, and hexokinase, are widely adopted due to their specificity and relative ease of use. However, they are hindered by issues of instability, environmental sensitivity, and interference from other biomolecules. Non-enzymatic sensors, which employ metals and nanomaterials for the direct oxidation of glucose, offer an attractive alternative. These platforms demonstrate higher sensitivity and cost-effectiveness, though they remain under refinement for routine use. Non-invasive glucose detection represents a futuristic leap in diabetes care. By leveraging alternative biofluids such as saliva, tears, sweat, and breath, these methods promise enhanced patient comfort and compliance. Nonetheless, their limited sensitivity continues to challenge widespread adoption. Looking forward, the integration of nanotechnology, wearable biosensors, and artificial intelligence paves the way for personalized, affordable, and patient-centered diabetes management, marking a transformative era in healthcare. This review explores the evolution of glucose monitoring, from early chemical assays to advanced state-of-the-art nanotechnology-based approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Materials for Medicine Research Group, School of Medicine, Royal College of Surgeons in Ireland, Medical University of Bahrain, Busaiteen 228, Bahrain.
ORCID-Profile: Abdullah Hussain, Abdulrahman Al-Majmuei, Mohammad Alatoom
Förderung
- School of Postgraduate Studies and Research, RCSI-Bahrain
Zitieren
APA
Waly, Y., Hussain, A., Al-Majmuei, A., Alatoom, M., Alaraibi, A. J., Alaysereen, A., & Deen, G. R. (2026). Evolution of Biosensors and Current State-of-the-Art Applications in Diabetes Control. Biosensors, 16(1), 39. https://doi.org/10.3390/bios16010039
Vancouver
Waly Y, Hussain A, Al-Majmuei A, Alatoom M, Alaraibi AJ, Alaysereen A, et al. Evolution of Biosensors and Current State-of-the-Art Applications in Diabetes Control. Biosensors. 2026;16(1):39. doi:10.3390/bios16010039
BibTeX
@article{Waly2026,
author = {Waly, Yahya and Hussain, Abdullah and Al-Majmuei, Abdulrahman and Alatoom, Mohammad and Alaraibi, Ahmed J and Alaysereen, Ahmed and Deen, G Roshan},
title = {Evolution of Biosensors and Current State-of-the-Art Applications in Diabetes Control},
journal = {Biosensors},
year = {2026},
volume = {16},
number = {1},
pages = {39},
doi = {10.3390/bios16010039}
}
EUVIMED